PAI Pharma is the leading developer, manufacturer, and distributor of generic oral liquids in ready-to-dose (RTD) cups and bottles within the United States. The company serves the pharmaceutical sector, including retail pharmacies, hospitals, long-term care facilities, and government agencies.
The company's portfolio comprises more than 60 prescription and over-the-counter therapies, available in forms such as suspensions, oral solutions, elixirs, and syrups. It holds over 250 product NDCs and utilizes its proprietary DURA-DOSE unit-dose packaging. PAI Pharma operates from a manufacturing facility exceeding 300,000 square feet and identifies itself as the largest Gx-liquid capacity manufacturer in the country.
PAI Pharma's operations are headquartered in Parsippany, New Jersey, with a major operational presence in Greenville, South Carolina. The company provides nationwide service across the United States.
